Skip to main content
. 1999 Jun;116(3):388–394. doi: 10.1046/j.1365-2249.1999.00879.x

Fig. 4.

Fig. 4

Killing of the Fas-sensitive targets (Jurkat and M-3) and Fas-resistant target (K-562) by CD4+ tumour-infiltrating lymphocyte (TIL) effectors kept in IL-2 at least 6 days after restimulation (IL-2 alone), or preactivated with anti-CD3 for 3 h. Anti-Fas (ZB-4) or EGTA were added to these CD3-stimulated cultures to determine the effect of these agents on tumour lysis.